BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-29.0%
5Y CAGR-17.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-29.0%/yr
vs -2.5%/yr prior
5Y CAGR
-17.6%/yr
Recent deceleration
Acceleration
-26.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.33 | -22.1% |
| 2024 | 4.27 | -44.0% |
| 2023 | 7.63 | -18.2% |
| 2022 | 9.32 | +3.3% |
| 2021 | 9.02 | +3.0% |
| 2020 | 8.76 | -4.1% |
| 2019 | 9.13 | -11.7% |
| 2018 | 10.34 | -15.8% |
| 2017 | 12.28 | -2.2% |
| 2016 | 12.56 | - |